This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Mechanical Circulatory Support During Surgical Revascularization for Ischemic Cardiomyopathy

Thursday, April 18, 2024

Submitted by


Source Name: The Annals of Thoracic Surgery


Sameer K. Singh, Alice Vinogradsky, Michael Kirschner, Jocelyn Sun, Chunhui Wang, Paul Kurlansky, Yuji Kaku, Craig R. Smith, Koji Takeda

This study aimed to describe the use of perioperative mechanical circulatory support (MCS) and its impact on outcomes in patients with ischemic cardiomyopathy undergoing surgical revascularization. Between 2015 and 2021, data from 378 patients with an ejection fraction below 35 percent and undergoing isolated coronary artery bypass grafting (CABG) were analyzed based on utilization of MCS—no MCS, preoperative MCS and postoperative MCS. Authors included patients requiring intra-aortic balloon pump, extracorporeal membrane oxygenation, or Impella device within the MCS groups. The primary outcome was operative mortality.

Add comment

Log in or register to post comments